Amanote Research
Register
Sign In
A Catecholamine Loop Mediates Cytokine Release Syndrome
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2019-002
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
January 4, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Cytokine Release Syndrome With Chimeric Antigen Receptor T Cell Therapy
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Mechanisms of Eosinophil Cytokine Release
Memorias do Instituto Oswaldo Cruz
Medicine
Microbiology
Neurological Toxicities and Coagulation Disorders in the Cytokine Release Syndrome During CAR-T Therapy
British Journal of Haematology
Hematology
The Cytokine Interleukin-33 Mediates Anaphylactic Shock
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Cytokine Release Syndrome and Neurotoxicity After CD19 Chimeric Antigen Receptor-Modified (CAR-) T Cell Therapy
British Journal of Haematology
Hematology
Granulocyte-Macrophage Colony-Stimulating Factor Inactivation in CAR T-Cells Prevents Monocyte-Dependent Release of Key Cytokine Release Syndrome Mediators
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Case Study: A Patient With Asthma, Covid-19 Pneumonia and Cytokine Release Syndrome Treated With Corticosteroids and Tocilizumab
Wits Journal of Clinical Medicine
Cytokine Release Syndrome With Pseudoprogression in a Patient With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Rapid Identification of Cytokine Release Syndrome After Haploidentical PBSC Transplantation and Successful Therapy With Tocilizumab
Bone Marrow Transplantation
Transplantation
Hematology
